Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec;83(6):e445.
doi: 10.1016/j.jaad.2020.07.097. Epub 2020 Jul 29.

In response to: "Reply to research letter"

Marilyn T Wan  1 , Daniel B Shin  1 , Kevin L Winthrop  2 , Joel M Gelfand  3
Affiliations
Comment

In response to: "Reply to research letter"

Marilyn T Wan et al. J Am Acad Dermatol. 2020 Dec.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Rivera-Oyola R., Koschitzky M., Lebwohl M. Reply to research letter. J Am Acad Dermatol. 2020;83(6):e443. - PMC - PubMed
    1. Wan M.T., Shin D.B., Winthrop K.L., Gelfand J.M. The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway-inhibiting biologics: a meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic. J Am Acad Dermatol. 2020;83(2):677–679. - PMC - PubMed
    1. Insani W.N., Pacurariu A.C., Mantel-Teeuwisse A.K., Gross-Martirosyan L. Characteristics of drugs safety signals that predict safety related product information update. Pharmacoepidemiol Drug Saf. 2018;27(7):789–796. - PMC - PubMed
    1. Syed M.N., Shin D.B., Wan M.T., Winthrop K.L., Gelfand J.M. The risk of respiratory tract infections in psoriasis patients treated with IL-23-pathway inhibiting biologics: a meta-estimate of pivotal trials relevant to decision-making during the COVID-19 pandemic. J Am Acad Dermatol. 2020 doi: 10.1016/j.jaad.2020.06.1014. - DOI - PMC - PubMed